Teclistamab-Associated Sclerouveitis with Hypopyon.

Tianyu Liu,Turner Schwartz, Apoorv P Chebolu,Jonathan C Tsui, Nirali Bhatt,Drew Scoles

Retinal cases & brief reports(2023)

引用 0|浏览1
暂无评分
摘要
Teclistamab, a novel bispecific antibody recently approved for the treatment of relapsed or refractory multiple myeloma, may be associated with sclerouveitis with hypopyon.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要